Shares of other companies:
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
Tesla Is An AI Company That The Market Won’t Reward For Now
April 24, 2024
Amazon: The Margin Train Is Gaining Speed
April 24, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
APVO Stock News and Mentions of Aptevo Therapeutics Inc. Stocktwits
Updated: April 28, 2024 (09:14)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Aptevo Therapeutics Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Aptevo Therapeutics Inc. (APVO).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Aptevo Therapeutics stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Aptevo Therapeutics Inc. (APVO)
April 24, 2024 (10:31) / "Zacks Commentary" (by Sanghamitra Saha)
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Groupon (GRPN), Aptevo Therapeutics (APVO), NewJersey Resources (NJR), American Water Works (AWK) and Frontdoor (FTDR).
In Article Trend: Somewhat-Bullish
April 18, 2024 (07:02) / "Stocknews.com" (by Defense World Staff)
StockNews.com Begins Coverage on Aptevo Therapeutics ( NASDAQ:APVO )
Stock analysts at StockNews.com assumed coverage on shares of Aptevo Therapeutics ( NASDAQ:APVO - Get Free Report ) in a report issued on Thursday. The firm set a "sell" rating on the biotechnology company's stock. Shares of NASDAQ APVO opened at $0.71 on Thursday.
In Article Trend: Somewhat-Bullish
April 16, 2024 (16:47) / "Zacks Commentary" (by Zacks Equity Research)
Aptevo ( APVO ) Stock Plummets 79% in a Week: Here's Why
Aptevo (APVO) plunges after it issues secondary shares, which are not only issued at a significant discount but also substantially dilute the existing shareholder base.
In Article Trend: Neutral
April 11, 2024 (19:21) / "Benzinga" (by Avi Kapoor)
Nasdaq Jumps 250 Points; Crude Oil Down 1% - Aptevo Therapeutics ( NASDAQ:APVO ) , Eliem Therapeutics ( NASDAQ:ELYM )
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83. The S&P 500 also rose, gaining, 0.83% to 5,203.26. Information technology shares rose by 2.2% on ...
In Article Trend: Neutral
April 11, 2024 (19:06) / "Benzinga" (by Erica Kollmann)
Why Aptevo Therapeutics Stock Is Cratering - Aptevo Therapeutics ( NASDAQ:APVO )
Aptevo Therapeutics Inc. APVO shares are trading lower Thursday after the company priced its $4.6 million public offering.
In Article Trend: Somewhat-Bullish
April 11, 2024 (15:55) / "Benzinga" (by Avi Kapoor)
Dow Dips 100 Points; CarMax Earnings Miss Views - CarMax ( NYSE:KMX )
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday. The Dow traded down 0.35% to 38,328.18 while the NASDAQ rose 0.50% to 16,251.71. The S&P 500 also rose, gaining, 0.03% to 5,162.19.Check This Out: How To Earn $500 A Month From ...
In Article Trend: Neutral
April 11, 2024 (13:41) / "Benzinga" (by Avi Kapoor)
Nasdaq Gains Over 50 Points; US Producer Prices Increase In March - Aptevo Therapeutics ( NASDAQ:APVO ) , ClearOne ( NASDAQ:CLRO )
U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94. The S&P 500 also rose, gaining, 0.17% to 5,169.21. Real estate shares rose by 0.6% on Thursday.
In Article Trend: Somewhat-Bullish
April 11, 2024 (10:14) / "Benzinga" (by Avi Kapoor)
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket - Rallybio ( NASDAQ:RLYB )
Shares of Rallybio Corporation RLYB rose sharply in today's pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Rallybio shares jumped rose 77.9% to $2.90 in pre-market trading.
In Article Trend: Neutral
April 10, 2024 (06:24) / "Stocknews.com" (by Defense World Staff)
Aptevo Therapeutics ( NASDAQ:APVO ) Earns Hold Rating from Analysts at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of Aptevo Therapeutics ( NASDAQ:APVO - Get Free Report ) in a research report issued on Wednesday. The firm set a "hold" rating on the biotechnology company's stock. Shares of NASDAQ:APVO opened at $3.26 on Wednesday.
In Article Trend: Bullish
April 2, 2024 (06:12) / "Stocknews.com" (by Defense World Staff)
Aptevo Therapeutics ( NASDAQ:APVO ) Coverage Initiated at StockNews.com
Research analysts at StockNews.com assumed coverage on shares of Aptevo Therapeutics ( NASDAQ:APVO - Get Free Report ) in a research note issued to investors on Tuesday. The brokerage set a "hold" rating on the biotechnology company's stock. APVO stock opened at $4.25 on Tuesday.
In Article Trend: Somewhat-Bullish
March 25, 2024 (06:18) / "Stocknews.com" (by Defense World Staff)
Aptevo Therapeutics ( NASDAQ:APVO ) Now Covered by StockNews.com
Investment analysts at StockNews.com started coverage on shares of Aptevo Therapeutics ( NASDAQ:APVO - Get Free Report ) in a research report issued to clients and investors on Monday. The brokerage set a "hold" rating on the biotechnology company's stock. NASDAQ APVO opened at $4.56 on Monday.
In Article Trend: Somewhat-Bullish
March 17, 2024 (06:16) / "Stocknews.com" (by Defense World Staff)
StockNews.com Begins Coverage on Aptevo Therapeutics ( NASDAQ:APVO )
StockNews.com started coverage on shares of Aptevo Therapeutics ( NASDAQ:APVO - Get Free Report ) in a research report issued to clients and investors on Sunday. The brokerage set a "hold" rating on the biotechnology company's stock. Aptevo Therapeutics stock opened at $5.42 on Friday.
In Article Trend: Somewhat-Bullish
March 9, 2024 (07:36) / "Stocknews.com" (by ABMN Staff)
Aptevo Therapeutics ( NASDAQ:APVO ) Now Covered by StockNews.com
Aptevo Therapeutics ( NASDAQ:APVO ) Now Covered by ...
In Article Trend: Somewhat-Bullish
March 9, 2024 (07:24) / "Stocknews.com" (by Defense World Staff)
Aptevo Therapeutics ( NASDAQ:APVO ) Now Covered by StockNews.com
Stock analysts at StockNews.com initiated coverage on shares of Aptevo Therapeutics ( NASDAQ:APVO - Get Free Report ) in a note issued to investors on Saturday. The firm set a "hold" rating on the biotechnology company's stock. Aptevo Therapeutics stock opened at $5.19 on Friday.
In Article Trend: Somewhat-Bullish
March 7, 2024 (18:45) / "Benzinga" (by Vandana Singh)
Why Is Aptevo Therapeutics Stock Trading Higher On Thursday? - Aptevo Therapeutics ( NASDAQ:APVO )
Thursday, Alligator Bioscience AB and Aptevo Therapeutics Inc APVO released interim data from the dose escalation phase of their Phase 1 trial evaluating ALG.APV-527 for solid tumors likely to express the tumor antigen 5T4.
In Article Trend: Neutral
March 1, 2024 (07:16) / "Stocknews.com" (by Defense World Staff)
Aptevo Therapeutics ( NASDAQ:APVO ) Now Covered by StockNews.com
StockNews.com initiated coverage on shares of Aptevo Therapeutics ( NASDAQ:APVO - Get Free Report ) in a research note issued on Friday. The brokerage set a "hold" rating on the biotechnology company's stock. NASDAQ APVO opened at $0.17 on Friday.
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website